AD BLOOD BIOMARKERS IN DIVERSE COMMUNITY SETTINGS: A LONGITUDINAL PERSPECTIVE FROM THE ARIC STUDY

Abstract

Alzheimer’s disease and related dementias (ADRD) feature a prolonged preclinical stage spanning decades, with the transition from mid- to late-life marking the critical period for onset and accumulation of pathological brain changes that may lead to physical and cognitive disability.